Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|3|204-207

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.3, 2015-03, pp. : 204-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 511-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Management of chronic lymphocytic leukemia (CLL) in the era of B‐cell receptor signal transduction inhibitors

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 657-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL14)

By  

Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. : 69-71

Karger

Access to resources Recommend Favorite

Treatment of Resistant/Relapsing Chronic Lymphocytic Leukemia with a Combination Regimen Containing Deoxycoformycin and Rituximab

By  

Acta Haematologica, Vol. 111, Iss. 4, 2004-05 ,pp. : 185-188

Karger

Access to resources Recommend Favorite